The Senate?s procedural vote this morning on the Dorgan prescription drug importation amendment is of serious concern. This amendment fails to sufficiently ensure the safety of imported products, and would open the door for counterfeit drugs to enter our domestic pharmaceutical supply. It would imperil the Food and Drug Administration?s (FDA) ability to protect American consumers from counterfeit and diverted drugs.
Today’s news that the Food and Drug Administration (FDA) is examining whether the maker of Zyprexa failed to submit clinical trial data about the harmful side effects of the antipsychotic drug underscores the urgent need for Congress to pass drug-safety legislation.
The vast majority of Americans want Medicare to negotiate for lower prescription drug prices. Seniors and their families know there is no logical reason the federal government should be prohibited from negotiating with drug makers except to preserve industry profits.
As US Congress prepares to vote on the most significant prescription drug safety legislation in 45 years, a new Consumer Reports poll finds that the American public strongly backs a host of key safety reforms.
The Washington State House of Representatives passed Senate Bill 5297 by a vote of 63-34, paving the way for comprehensive sex education ? education that includes scientifically accurate information on abstinence and the health benefits of birth control and condoms ? to be taught in the state?s schools.
AARP will be sending the following letter from CEO Bill Novelli to every member of the U.S. Senate alerting them that the association will be recording the upcoming Senate vote on a bill to allow Medicare to negotiate for lower prescription drug prices.
AARP CEO Bill Novelli released the following statement today after the U.S. Senate Finance Committee passed a bill to give Medicare the power to bargain for lower drug prices (S. 3) with a bipartisan vote.
The Juvenile Diabetes Research Foundation, the world?s largest charitable funder of type 1 diabetes research, praised today?s historic vote in the U.S. Senate to expand federal funding for embryonic stem cell research with the passage of S. 5, the Stem Cell Research Enhancement Act of 2007.
A leading expert on modern day management of cancer is calling for the implementation of proper procedures that would allow NHS patients to top up cancer care in the private sector.
US President Bush would veto legislation requiring the government to negotiate with drug companies for lower prices under Medicare. The House is to debate and vote on the bill on friday.